author_facet Hernandez, J.M.
Paty, J.
Price, I.
Hernandez, J.M.
Paty, J.
Price, I.
author Hernandez, J.M.
Paty, J.
Price, I.
spellingShingle Hernandez, J.M.
Paty, J.
Price, I.
CJEM
P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
Emergency Medicine
author_sort hernandez, j.m.
spelling Hernandez, J.M. Paty, J. Price, I. 1481-8035 1481-8043 Springer Science and Business Media LLC Emergency Medicine http://dx.doi.org/10.1017/cem.2016.236 <jats:p><jats:bold>Introduction:</jats:bold> Cannabinoid hyperemesis syndrome (CHS) is a paradoxical side effect of cannabis use. Patients with CHS often present multiple times to the Emergency Department (ED) with cyclical nausea, vomiting and abdominal pain, and are discharged with various misdiagnoses. CHS studies to date are limited to case series. We examined the epidemiology of CHS cases presenting to two major urban Tertiary Care Centre EDs. <jats:bold>Methods:</jats:bold> Using explicit variables, trained abstractors, and standardized abstraction forms, we abstracted data for all adults (18-55 years) with a presenting complaint of vomiting, and/or a discharge diagnosis of vomiting and/or cyclical vomiting, during a 2-year period. Inter-rater agreement was measured using a kappa statistic. <jats:bold>Results:</jats:bold> We identified 494 cases: mean age 31 years; 36% male; only 19.4% of charts specifically reported cannabis use. Among the regular cannabis users (&gt;3 times per week), 43% had repeat ED visits for similar complaints. Interestingly, of these patients, 92% had bloodwork done in the ED, 92% received IV fluids, 89% received anti-emetics, 27% received opiates, 19% underwent imaging, 8% were admitted to hospital, and 8% were referred to the Gastroentorology service. Inter-rater reliability for data abstraction was kappa = 1. <jats:bold>Conclusion:</jats:bold> This study suggests CHS may be an overlooked diagnosis for nausea and vomiting, a factor which can possibly contribute to unnecessary investigations and treatment in the ED. Additionally, this indicates a lack of screening for CHS on ED history, especially in quantifying cannabis use and eliciting associated symptoms of CHS.</jats:p> P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study CJEM
doi_str_mv 10.1017/cem.2016.236
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNy9jZW0uMjAxNi4yMzY
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNy9jZW0uMjAxNi4yMzY
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint Springer Science and Business Media LLC, 2016
imprint_str_mv Springer Science and Business Media LLC, 2016
issn 1481-8035
1481-8043
issn_str_mv 1481-8035
1481-8043
language English
mega_collection Springer Science and Business Media LLC (CrossRef)
match_str hernandez2016p060cannabinoidhyperemesissyndromepresentationtotheemergencydepartmentatwoyearmulticentreretrospectivestudy
publishDateSort 2016
publisher Springer Science and Business Media LLC
recordtype ai
record_format ai
series CJEM
source_id 49
title P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_unstemmed P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_full P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_fullStr P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_full_unstemmed P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_short P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_sort p060: cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
topic Emergency Medicine
url http://dx.doi.org/10.1017/cem.2016.236
publishDate 2016
physical S98-S99
description <jats:p><jats:bold>Introduction:</jats:bold> Cannabinoid hyperemesis syndrome (CHS) is a paradoxical side effect of cannabis use. Patients with CHS often present multiple times to the Emergency Department (ED) with cyclical nausea, vomiting and abdominal pain, and are discharged with various misdiagnoses. CHS studies to date are limited to case series. We examined the epidemiology of CHS cases presenting to two major urban Tertiary Care Centre EDs. <jats:bold>Methods:</jats:bold> Using explicit variables, trained abstractors, and standardized abstraction forms, we abstracted data for all adults (18-55 years) with a presenting complaint of vomiting, and/or a discharge diagnosis of vomiting and/or cyclical vomiting, during a 2-year period. Inter-rater agreement was measured using a kappa statistic. <jats:bold>Results:</jats:bold> We identified 494 cases: mean age 31 years; 36% male; only 19.4% of charts specifically reported cannabis use. Among the regular cannabis users (&gt;3 times per week), 43% had repeat ED visits for similar complaints. Interestingly, of these patients, 92% had bloodwork done in the ED, 92% received IV fluids, 89% received anti-emetics, 27% received opiates, 19% underwent imaging, 8% were admitted to hospital, and 8% were referred to the Gastroentorology service. Inter-rater reliability for data abstraction was kappa = 1. <jats:bold>Conclusion:</jats:bold> This study suggests CHS may be an overlooked diagnosis for nausea and vomiting, a factor which can possibly contribute to unnecessary investigations and treatment in the ED. Additionally, this indicates a lack of screening for CHS on ED history, especially in quantifying cannabis use and eliciting associated symptoms of CHS.</jats:p>
container_issue S1
container_start_page 0
container_title CJEM
container_volume 18
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792326811766489100
geogr_code not assigned
last_indexed 2024-03-01T12:27:09.17Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=P060%3A+Cannabinoid+hyperemesis+syndrome+presentation+to+the+emergency+department%3A+a+two-year+multi-centre+retrospective+study&rft.date=2016-05-01&genre=article&issn=1481-8043&volume=18&issue=S1&pages=S98-S99&jtitle=CJEM&atitle=P060%3A+Cannabinoid+hyperemesis+syndrome+presentation+to+the+emergency+department%3A+a+two-year+multi-centre+retrospective+study&aulast=Price&aufirst=I.&rft_id=info%3Adoi%2F10.1017%2Fcem.2016.236&rft.language%5B0%5D=eng
SOLR
_version_ 1792326811766489100
author Hernandez, J.M., Paty, J., Price, I.
author_facet Hernandez, J.M., Paty, J., Price, I., Hernandez, J.M., Paty, J., Price, I.
author_sort hernandez, j.m.
container_issue S1
container_start_page 0
container_title CJEM
container_volume 18
description <jats:p><jats:bold>Introduction:</jats:bold> Cannabinoid hyperemesis syndrome (CHS) is a paradoxical side effect of cannabis use. Patients with CHS often present multiple times to the Emergency Department (ED) with cyclical nausea, vomiting and abdominal pain, and are discharged with various misdiagnoses. CHS studies to date are limited to case series. We examined the epidemiology of CHS cases presenting to two major urban Tertiary Care Centre EDs. <jats:bold>Methods:</jats:bold> Using explicit variables, trained abstractors, and standardized abstraction forms, we abstracted data for all adults (18-55 years) with a presenting complaint of vomiting, and/or a discharge diagnosis of vomiting and/or cyclical vomiting, during a 2-year period. Inter-rater agreement was measured using a kappa statistic. <jats:bold>Results:</jats:bold> We identified 494 cases: mean age 31 years; 36% male; only 19.4% of charts specifically reported cannabis use. Among the regular cannabis users (&gt;3 times per week), 43% had repeat ED visits for similar complaints. Interestingly, of these patients, 92% had bloodwork done in the ED, 92% received IV fluids, 89% received anti-emetics, 27% received opiates, 19% underwent imaging, 8% were admitted to hospital, and 8% were referred to the Gastroentorology service. Inter-rater reliability for data abstraction was kappa = 1. <jats:bold>Conclusion:</jats:bold> This study suggests CHS may be an overlooked diagnosis for nausea and vomiting, a factor which can possibly contribute to unnecessary investigations and treatment in the ED. Additionally, this indicates a lack of screening for CHS on ED history, especially in quantifying cannabis use and eliciting associated symptoms of CHS.</jats:p>
doi_str_mv 10.1017/cem.2016.236
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNy9jZW0uMjAxNi4yMzY
imprint Springer Science and Business Media LLC, 2016
imprint_str_mv Springer Science and Business Media LLC, 2016
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 1481-8035, 1481-8043
issn_str_mv 1481-8035, 1481-8043
language English
last_indexed 2024-03-01T12:27:09.17Z
match_str hernandez2016p060cannabinoidhyperemesissyndromepresentationtotheemergencydepartmentatwoyearmulticentreretrospectivestudy
mega_collection Springer Science and Business Media LLC (CrossRef)
physical S98-S99
publishDate 2016
publishDateSort 2016
publisher Springer Science and Business Media LLC
record_format ai
recordtype ai
series CJEM
source_id 49
spelling Hernandez, J.M. Paty, J. Price, I. 1481-8035 1481-8043 Springer Science and Business Media LLC Emergency Medicine http://dx.doi.org/10.1017/cem.2016.236 <jats:p><jats:bold>Introduction:</jats:bold> Cannabinoid hyperemesis syndrome (CHS) is a paradoxical side effect of cannabis use. Patients with CHS often present multiple times to the Emergency Department (ED) with cyclical nausea, vomiting and abdominal pain, and are discharged with various misdiagnoses. CHS studies to date are limited to case series. We examined the epidemiology of CHS cases presenting to two major urban Tertiary Care Centre EDs. <jats:bold>Methods:</jats:bold> Using explicit variables, trained abstractors, and standardized abstraction forms, we abstracted data for all adults (18-55 years) with a presenting complaint of vomiting, and/or a discharge diagnosis of vomiting and/or cyclical vomiting, during a 2-year period. Inter-rater agreement was measured using a kappa statistic. <jats:bold>Results:</jats:bold> We identified 494 cases: mean age 31 years; 36% male; only 19.4% of charts specifically reported cannabis use. Among the regular cannabis users (&gt;3 times per week), 43% had repeat ED visits for similar complaints. Interestingly, of these patients, 92% had bloodwork done in the ED, 92% received IV fluids, 89% received anti-emetics, 27% received opiates, 19% underwent imaging, 8% were admitted to hospital, and 8% were referred to the Gastroentorology service. Inter-rater reliability for data abstraction was kappa = 1. <jats:bold>Conclusion:</jats:bold> This study suggests CHS may be an overlooked diagnosis for nausea and vomiting, a factor which can possibly contribute to unnecessary investigations and treatment in the ED. Additionally, this indicates a lack of screening for CHS on ED history, especially in quantifying cannabis use and eliciting associated symptoms of CHS.</jats:p> P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study CJEM
spellingShingle Hernandez, J.M., Paty, J., Price, I., CJEM, P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study, Emergency Medicine
title P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_full P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_fullStr P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_full_unstemmed P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_short P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_sort p060: cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
title_unstemmed P060: Cannabinoid hyperemesis syndrome presentation to the emergency department: a two-year multi-centre retrospective study
topic Emergency Medicine
url http://dx.doi.org/10.1017/cem.2016.236